Apple Inc
Change company Symbol lookup
Select an option...
AAPL Apple Inc
BAC Bank of America Corp
KO Coca-Cola Co
HXL Hexcel Corp
RDHL Redhill Biopharma Ltd
WASH Washington Trust Bancorp Inc
ADC Agree Realty Corp
FB Facebook Inc
HSTM HealthStream Inc

Information Technology : Technology Hardware, Storage & Peripherals | Large Cap BlendCompany profile

Apple Inc. designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players. The Company sells a range of related software, services, accessories, networking solutions, and third-party digital content and applications. The Company's segments include the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. The Americas segment includes both North and South America. The Europe segment includes European countries, India, the Middle East and Africa. The Greater China segment includes China, Hong Kong and Taiwan. The Rest of Asia Pacific segment includes Australia and the Asian countries not included in the Company's other operating segments. Its products and services include iPhone, iPad, Mac, iPod, Apple Watch, Apple TV, a portfolio of consumer and professional software applications, iPhone OS (iOS), OS X and watchOS operating systems, iCloud, Apple Pay and a range of accessory, service and support offerings.


Last Trade
-0.69 (-0.33%)
B/A Size

Market Hours

Closing Price
Day's Change
1.62 (0.78%)
Bid close
Ask close
B/A Size
Day's High
Day's Low

10-day average volume:

Phoenix Life Announces Annual Financial Report Filings for 2017 and 2018

9:01 am ET April 26, 2019 (Globe Newswire) Print

via NEWMEDIAWIRE - Phoenix Life Sciences International Limited (OTC: PLSI) ("Phoenix Life", the "Company"), an international adaptive healthcare solutions company, today announced that it has completed filing its Form 10-Quarterly Reports and Form 10-K Annual Reports, including audited financial reports, with the Securities and Exchange Commission ("SEC") for the 2017 and 2018 fiscal years as part of the Company's 2018 merger and consolidation.

Phoenix Life was created through a consolidation of multiple domestic and international businesses. The filing of these 2017 and 2018 reports, and subsequent quarterly reports, will bring the Company current with its reporting requirements with the SEC. Phoenix Life intends to remain a fully reporting public company to provide full transparency with the SEC and investing public.

Following OTC Markets update of reporting status to current, Phoenix Life intends to begin the process of uplisting onto the OTCQB market, in parallel with launching a capital offering to fund the next stages of development and execution for the Company.

"The Phoenix Life team has been working diligently to bring the reports of the Company current including all reports pre and post-merger. Complete transparency in all aspects of our business remains a high priority," said Martin Tindall, CEO and Founder of Phoenix Life. "As Phoenix Life moves forward with the legal global distribution of its medical cannabis derived pharmaceutical products and programs for managing healthcare, our underlying corporate compliance is a key priority for the Company."

In March 2019, Phoenix Life announced the filing its 2015 and 2016 Form 10-K Annual Reports.

The Company is currently performing widespread diabetes screenings across the Republic of Vanuatu in advance of launching clinical trials on the efficacy of its diabetes treatment in conjunction with leading Australian Universities and Ethics Committees.

To learn more about Phoenix Life Sciences International, please visit

About Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited is an adaptive healthcare solutions company. Our business is to advance research and integrate programs and manufacturing of products that target and treat diabetes, pain, cancer, and address psychological, gastrointestinal, autoimmune, neurological and sleep disorders. We strive to create partnerships and integrate these programs for human health into communities worldwide as part of our Global Health Initiative.


Information contained in this press release regarding Phoenix Life Sciences International, Limited and its subsidiaries, (the "Companies") may constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements. The words "plan", "forecast", "anticipates", "estimate", "project", "intend", "expect", "should", "believe," and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to, known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to the Companies herein are expressly qualified in their entirety by the above-mentioned cautionary statement. The Companies disclaim any obligation to update forward-looking statements contained in this press release, except as may be required by law.


These statements have not been evaluated by the FDA and therefore the products sold by Phoenix Life Sciences International are not available in the U.S.


Phoenix Life Sciences International does not sell or distribute any products in the United States that are in violation of the United States Controlled Substances Act (US.CSA). This company does not grow, sell, and distribute cannabis-based products in the United States and is solely involved with the legal distribution of medical cannabis-based products within certain international markets outside of the United States.

Investor Contact:

Phone: 1.888.717.5655 or international +1.720.699.7222


Media Contact:

Kathryn Reinhardt

CMW Media


Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.